Sarepta Therapeutics Inc (SRPT)
116.51
-1.38
(-1.17%)
USD |
NASDAQ |
Apr 18, 16:00
116.52
+0.01
(+0.01%)
After-Hours: 20:00
Sarepta Therapeutics Cash from Investing (TTM): -165.80M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -165.80M |
| September 30, 2023 | -91.65M |
| June 30, 2023 | 138.04M |
| March 31, 2023 | -248.58M |
| December 31, 2022 | -1.047B |
| September 30, 2022 | -1.059B |
| June 30, 2022 | -1.058B |
| March 31, 2022 | -447.06M |
| December 31, 2021 | 495.41M |
| September 30, 2021 | 374.10M |
| June 30, 2021 | 407.91M |
| March 31, 2021 | 52.62M |
| December 31, 2020 | -121.72M |
| September 30, 2020 | 19.25M |
| June 30, 2020 | -52.78M |
| March 31, 2020 | 133.81M |
| December 31, 2019 | 286.72M |
| September 30, 2019 | 31.91M |
| June 30, 2019 | -13.53M |
| March 31, 2019 | -221.00M |
| December 31, 2018 | -370.49M |
| September 30, 2018 | -626.45M |
| June 30, 2018 | -438.10M |
| March 31, 2018 | -403.06M |
| December 31, 2017 | -178.82M |
| Date | Value |
|---|---|
| September 30, 2017 | 116.11M |
| June 30, 2017 | 1.381M |
| March 31, 2017 | 100.37M |
| December 31, 2016 | -90.19M |
| September 30, 2016 | 38.76M |
| June 30, 2016 | 59.56M |
| March 31, 2016 | -16.00M |
| December 31, 2015 | 8.41M |
| September 30, 2015 | 124.91M |
| June 30, 2015 | 73.35M |
| March 31, 2015 | 67.09M |
| December 31, 2014 | -159.03M |
| September 30, 2014 | -206.53M |
| June 30, 2014 | -187.66M |
| March 31, 2014 | -186.24M |
| December 31, 2013 | -11.67M |
| September 30, 2013 | -11.27M |
| June 30, 2013 | -9.677M |
| March 31, 2013 | -8.603M |
| December 31, 2012 | -1.145M |
| September 30, 2012 | -1.506M |
| June 30, 2012 | -1.745M |
| March 31, 2012 | -2.231M |
| December 31, 2011 | -2.305M |
| September 30, 2011 | -2.028M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.059B
Minimum
Sep 2022
495.41M
Maximum
Dec 2021
-124.51M
Average
-13.53M
Median
Jun 2019
Cash from Investing (TTM) Benchmarks
| CytomX Therapeutics Inc | -150.67M |
| PTC Therapeutics Inc | -176.74M |
| Vertex Pharmaceuticals Inc | -3.142B |
| Puma Biotechnology Inc | -19.12M |
| Regenxbio Inc | 190.94M |